Osobní účet
Osobní účet
Century Therapeutics
developer of allogeneic living drugs created to offer treatment for cancer
Stránky společnostiRok založení
2018
Uzávěrka
9/1/2021
Ziskovost
34%
O společnosti
Total Funding
$560M
Century Therapeutics is a developer of allogeneic living drugs created to offer treatment for cancer. The company's genetically-engineered, iPSC-derived immune effector cell products are designed to specifically target hematologic and solid cancers by harnessing the power of adult stem cells, providing patients with an unparalleled opportunity to advance the course of cancer care.
Number of employees
100-150
Headquarters
Philadelphia, Pennsylvania, United States